Written by Klarity Editorial Team
Published: May 7, 2026

If you’re a psychiatrist or psychiatric nurse practitioner considering telehealth, you’re probably asking: Can I actually prescribe antidepressants remotely? What about my scope of practice in different states? Will insurance even pay me for virtual med checks?
The short answer: Yes, you can manage depression medications via telehealth — but the details depend heavily on your credentials (MD vs PMHNP) and which state your patients are in.
Here’s what actually matters for your practice.
Unlike ADHD or chronic pain management, treating depression via telehealth is relatively straightforward. Why? First-line antidepressants (SSRIs, SNRIs, etc.) aren’t controlled substances. You don’t face the strict DEA prescribing barriers that apply to stimulants or opioids.
What you can do via video:
For controlled adjuncts (like a benzodiazepine for severe anxiety or sleep meds), temporary federal waivers allow tele-prescribing without an initial in-person visit through at least the end of 2025 — with new permanent DEA rules expected soon.
The telehealth medium doesn’t limit your clinical capability. The real considerations are licensing, scope of practice, and getting paid properly.
If you’re an MD or DO psychiatrist, you have full prescriptive authority in all states for depression treatment. No supervisory agreements. No formulary restrictions. No disease-specific limitations.
What this means practically:
The only constraint: state licensure. You must be licensed where the patient is physically located during the telehealth session. But once you have the license, you’re practicing at full scope — no different from your office-based authority.
This is where it gets complicated. Psychiatric nurse practitioners face a patchwork of state laws that range from full autonomy to physician-supervised practice.
New York leads the pack. As of 2022, experienced NPs (3,600+ practice hours) no longer need collaborative agreements. A PMHNP in NY can independently evaluate, diagnose, and prescribe for depression — functionally equivalent to an MD’s authority.
California is transitioning. Under AB 890 (passed 2020), experienced NPs can now practice without physician supervision in healthcare facilities (since 2023), and by January 2026, qualified NPs can practice independently even in private practice settings once they obtain Board certification. For depression management, this means a certified CA PMHNP can prescribe antidepressants, order labs, and manage care autonomously — no MD oversight required.
Pennsylvania requires PMHNPs to maintain a collaborative agreement with a physician to prescribe. The physician doesn’t co-sign every script, but the formal oversight agreement must be on file with the State Board.
Illinois has a hybrid model: newer NPs need collaborative agreements, but after 4,000 hours of practice plus additional training, NPs can apply for Full Practice Authority. However, even FPA NPs in Illinois must have a physician consultation agreement for certain controlled substances like benzodiazepines.
Texas is one of the most restrictive. PMHNPs cannot prescribe anything — including SSRIs — without an MD’s delegation. You need a formal Prescriptive Authority Agreement with a supervising physician, including regular chart reviews and periodic face-to-face meetings. Texas doesn’t allow NP prescribing of Schedule II substances in outpatient settings at all.
Florida created an ‘autonomous practice’ category for NPs in 2020, but psychiatric NPs were explicitly excluded. PMHNPs in Florida still need a written protocol with a supervising physician. They can prescribe under that protocol, but the physician oversight is legally mandatory.
If you’re a PMHNP in New York or (soon) California, you can join a telehealth platform and practice almost identically to a psychiatrist — evaluating patients, prescribing independently, managing your own panel.
If you’re in Pennsylvania or Illinois, the telehealth company needs to facilitate a collaborating physician relationship. Doable, but adds administrative complexity.
If you’re in Texas or Florida, you’ll need active physician supervision. Many platforms handle this by pairing NPs with consulting psychiatrists, but it limits your autonomy and potentially your earning power (since the supervising MD may take a cut or administrative fee).
For psychiatrists, this creates opportunity: platforms operating in restricted states need you either as direct providers or as collaborating physicians for NP teams.
One of the biggest telehealth wins for mental health providers: insurance pays the same for virtual visits as in-person in most cases.
Telehealth parity laws exist in 44 states plus DC, with 23 states explicitly requiring equal payment for telehealth services. Among our priority states:
What you’ll actually get paid:
For a typical 30-minute depression medication follow-up (CPT 99214), national average private insurance reimbursement runs $120–$130. A shorter 15-minute visit (99213) pays around $80–$100.
Medicare has extended telehealth mental health coverage through 2025 (and likely beyond), paying standard Physician Fee Schedule rates — roughly $115 for 99214, $80 for 99213.
One catch for NPs: Medicare pays 85% of the physician fee schedule for services billed under a nurse practitioner’s NPI. So while a psychiatrist gets $115 for a 99214, an NP would receive about $98 for the identical service. Not huge, but worth knowing if you’re comparing compensation models.
Initial psychiatric evaluations (60-minute, using codes like 90792 or complex E/M codes) typically reimburse $200+ from most payers.
The economics work. Medication management lends itself to shorter, more frequent visits (15-30 minutes), allowing you to see more patients than if you were doing hour-long therapy. With telehealth removing commute time and geographic barriers, you can build a sustainable practice treating depression patients across your licensed states.
Depression treatment demand is massive nationwide, but some states face critical shortages:
Texas: Only 1 psychiatrist per ~9,000 residents. PMHNPs face strict supervision requirements, creating a bottleneck. If you’re an MD, Texas patients need you desperately — and telehealth lets you reach underserved areas without relocating.
Florida: Similar ratio (~1:8,500), also with restricted PMHNP practice. High retiree population with significant depression prevalence. Telehealth particularly valuable for reaching rural Florida and avoiding office overhead in expensive markets like Miami or Naples.
New York: Much better psychiatrist supply in NYC (~1:2,900 statewide), but upstate rural areas remain underserved. Full NP practice authority means platforms can deploy PMHNPs effectively across the state.
California, Pennsylvania, Illinois: Moderate supply in urban centers, shortages elsewhere. California’s evolving NP independence creates new opportunities as experienced PMHNPs gain autonomy by 2026.
Here’s what most providers don’t think about: patient acquisition cost.
If you try to build a depression treatment practice from scratch — SEO, Google Ads, Psychology Today listings, Zocdoc — you’re realistically spending $200-500+ per qualified patient when you factor in:
Google Ads for mental health keywords run $15-40+ per click, and most clicks don’t convert to booked patients. Psychology Today charges monthly fees and puts you in competition with hundreds of other providers on the same search page.
Platforms like Klarity Health flip the model: you pay only when a qualified patient actually books with you. No upfront marketing spend. No monthly subscription fees gambling on whether traffic converts. No wasted ad budget.
You get:
For depression specifically, this matters because patients actively seeking medication management tend to be higher intent — they know they need treatment, they’re ready to start. Compare that to cold leads from a general ‘find a therapist’ directory where half are just browsing.
The economic reality: instead of spending $3,000-5,000/month on marketing with uncertain ROI, you pay a standard listing fee per new patient. That’s guaranteed ROI — you only invest when you’re already seeing the patient.
Initial evaluation (45-60 min):
Follow-up visits (15-30 min):
Best practice: Schedule frequent brief check-ins in the first 8-12 weeks of antidepressant treatment (every 2-4 weeks). Telehealth makes this easy — patients don’t need to take time off work or arrange childcare for a 20-minute med check.
Lab coordination: If you need to rule out medical causes (thyroid issues, vitamin deficiencies), you order labs and patients get bloodwork done locally. Results come back to you electronically.
Safety considerations: Suicide risk assessment is critical in depression treatment. Telehealth doesn’t limit this — you conduct the same risk screening, document emergency contacts, ensure patients have crisis resources (988 Suicide & Crisis Lifeline), and involve family/supports when appropriate.
Most depression treatment doesn’t require controlled medications. But when patients have comorbid anxiety or insomnia, you might prescribe benzodiazepines, hypnotics, or occasionally stimulants for treatment-resistant depression.
Current federal policy (extended through end of 2025): You can prescribe controlled substances via telehealth without an initial in-person visit. This temporary DEA flexibility, originally a COVID measure, keeps getting extended because it works — particularly for mental health.
State-specific notes:
New permanent DEA rules are expected by late 2025, likely codifying telehealth prescribing flexibilities for mental health treatment given bipartisan support and clinical evidence.
If you’re a psychiatrist: Yes, absolutely. Get licensed in your target states (Interstate Compact makes this easier), join a credible platform, and you can treat depression patients via telehealth with zero scope-of-practice limitations. You’ll get paid comparably to office visits, avoid practice overhead, and reach patients who desperately need care.
If you’re a PMHNP: It depends on your state. In full practice states (NY, soon CA), you’re essentially on par with MDs. In reduced practice states (PA, IL), you’ll need collaborative agreements but can still build a robust telehealth practice. In restricted states (TX, FL), physician supervision is mandatory — but platforms can facilitate this if the economics work.
Why this matters now: Behavioral health is the one area of telehealth with permanent momentum. Mental health visits via telehealth remain 20x higher than pre-2019 levels. Parity laws are expanding, not contracting. Medicare and private insurers have embraced virtual psychiatric care because outcomes are equivalent and patients actually show up to appointments.
Depression treatment is particularly well-suited to this model — frequent shorter visits, non-controlled medications for most patients, high demand, and demonstrated effectiveness via telehealth.
The question isn’t whether you can prescribe for depression via telehealth. You can.
The question is whether you’re willing to navigate the licensing and scope-of-practice requirements to tap into a patient population that needs you — and a practice model that removes the traditional barriers (overhead, marketing costs, geographic limits) that make mental health practice financially challenging.
Platforms like Klarity Health handle the hard parts — patient acquisition, credentialing support across states, EHR and e-prescribing infrastructure, billing. You focus on what you trained for: evaluating patients, prescribing appropriately, and actually improving people’s lives.
Ready to explore how telehealth depression treatment fits your practice goals? Join Klarity’s provider network and talk to our team about licensure support, patient volume in your target states, and what your schedule could realistically look like. No upfront costs, no marketing gambles — just qualified patients who need your expertise.
Can a PMHNP prescribe antidepressants without a psychiatrist in all states?
No. PMHNPs have independent prescribing authority in full practice states like New York and (by 2026) California. In states like Texas, Florida, and Pennsylvania, PMHNPs must work under physician supervision or collaborative agreements to prescribe any medications, including antidepressants.
Do I need a DEA license to prescribe SSRIs via telehealth?
For non-controlled antidepressants (SSRIs, SNRIs), you don’t need a DEA registration — just your state medical or nursing license and prescriptive authority. However, if you prescribe any controlled substances (benzodiazepines, stimulants, sleep aids), you’ll need your own DEA registration in addition to your license.
Will Medicare pay me the same for telehealth visits as in-person?
For psychiatrists: Yes, Medicare pays the same Physician Fee Schedule rate for telehealth mental health services through at least 2025. For PMHNPs: Medicare pays 85% of the physician rate when you bill under your own NPI, which is standard for all NP services under Medicare rules.
Can I treat patients in multiple states via telehealth?
Yes, but you must hold a license in each state where your patients are located during the telehealth session. The Interstate Medical Licensure Compact (37 participating states) expedites multi-state licensing for physicians. NPs must apply for licenses state-by-state, though some states have expedited endorsement for experienced providers.
What happens if I need to prescribe a controlled substance for a depression patient via telehealth?
Under current federal rules (extended through end of 2025), you can prescribe controlled substances via telehealth without an initial in-person exam for mental health treatment. Check your state’s specific requirements — some impose additional restrictions on NP controlled substance prescribing or require consultation agreements.
How do I handle safety concerns like suicidality in telehealth depression treatment?
Same standard of care as in-person: conduct thorough suicide risk assessments, document emergency contacts, ensure patients have crisis resources (988 Lifeline), develop safety plans, and involve family/supports when appropriate. Document everything. If a patient is acutely unsafe, facilitate emergency services in their location — most telehealth platforms have protocols for this.
New York State Budget 2022 – Nurse Practitioner Modernization Act. JD Supra Legal News (Rivkin Radler LLP), April 13, 2022. Available at: www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/
American Association of Nurse Practitioners. State Practice Environment: Texas. Accessed February 2026. Available at: www.aanp.org/advocacy/texas
Florida Advanced Practice Registered Nurse Association. Past New Laws – HB 607 (APRN Autonomous Practice). Updated 2024. Available at: www.flanp.org/page/PastNewLaws
Texas Nurse Practitioners. News, Laws and Regulations – DEA Telemedicine Prescribing Extension. October 6, 2023. Available at: texasnp.org/news-laws-and-regulations/
Axios News. ‘COVID telehealth prescribing extended through 2025 for Adderall, other drugs.’ November 18, 2024. Available at: www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall
California Legislature. Assembly Bill 890 Full Text (2019-2020 Session). Approved September 29, 2020. Available at: www.leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201920200AB890
iCanotes (Dr. October Boyles). ‘Telehealth Parity Laws: What Mental Health Providers Need to Know.’ Updated August 6, 2025. Available at: www.icanotes.com/2022/03/09/telehealth-parity-laws/
PayerPrice.com. ‘CPT Code 99214 Fee Schedule & Reimbursement Rates by Payer.’ Verified February 2026. Available at: payerprice.com/rates/99214-CPT-fee-schedule
LegalClarity.org. ‘Medicare Nurse Practitioner Coverage and Reimbursement Guide.’ December 17, 2025. Available at: legalclarity.org/medicare-nurse-practitioner-coverage-and-reimbursement/
Healing Psychiatry of Florida. ‘Psychiatrist Shortage by State: 2026 Rankings and Data.’ January 15, 2026. Available at: www.healingpsychiatryflorida.com/blogs/psychiatrist-shortage-by-state/
All sources accessed and verified February 2026. State regulatory information cross-referenced with official state board websites and recent legislative updates where applicable.
Find the right provider for your needs — select your state to find expert care near you.